Journal
NATURE BIOTECHNOLOGY
Volume 40, Issue 6, Pages 809-811Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41587-022-01362-7
Keywords
-
Categories
Ask authors/readers for more resources
The first herpesvirus replacement gene therapy for epidermolysis bullosa, a blistering skin condition, is approaching clinical trials.
The first herpesvirus replacement gene therapy for epidermolysis bullosa, a blistering skin condition, approaches the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
